Literature DB >> 28801923

Sensitive liquid chromatography/tandem mass spectrometry method for the determination of two novel highly lipophilic anticancer drug candidates in rat plasma and tissues.

Shirin Hooshfar1, Michael R Linzey1, Daqing Wu2, Lajos Gera3, Kenza Mamouni2, Xin Li2, Yanhua Chen2, Yang Yang2, Oluwasegun Olorunyolemi1, Michael G Bartlett1.   

Abstract

A simple and sensitive liquid chromatography/electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) method was developed and validated for determination of two highly lipophilic anticancer drug candidates, LG1980 and GH501, in rat plasma and tissues (liver, kidney and femur bones). LG1980 and GH501 were extracted from rat plasma and tissue homogenates using liquid-liquid extraction. The method provided a linear range of 1.0-200.0 ng/mL for GH501 in plasma and LG1980 in plasma and liver. For both analytes in other tissue homogenates the linear range was 2.0-400.0 ng/mL. The method was validated with precision within 15% relative standard deviation, accuracy within 15% relative error and a consistent recovery. This method has been successfully applied in two preclinical studies for LG1980 and GH501 to determine their concentrations in rat plasma, liver, kidney and bone over 24 h after intravenous injection of compounds.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS/MS; bioanalysis; highly lipophilic drug; plasma; tissue

Mesh:

Substances:

Year:  2017        PMID: 28801923      PMCID: PMC5786476          DOI: 10.1002/bmc.4064

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  13 in total

1.  Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells.

Authors:  Shumin Zhang; Yanru Wang; Zhengjia Chen; Sungjin Kim; Shareen Iqbal; Andrew Chi; Chad Ritenour; Yongqiang A Wang; Omer Kucuk; Daqing Wu
Journal:  Prostate       Date:  2013-09-02       Impact factor: 4.104

2.  A rapid analytical method for the quantification of paclitaxel in rat plasma and brain tissue by high-performance liquid chromatography and tandem mass spectrometry.

Authors:  Pei Li; Benjamin J Albrecht; Xisheng Yan; Mei Gao; Han-Rong Weng; Michael G Bartlett
Journal:  Rapid Commun Mass Spectrom       Date:  2013-10-15       Impact factor: 2.419

3.  Biomimetic reassembled chylomicrons as novel association model for the prediction of lymphatic transportation of highly lipophilic drugs via the oral route.

Authors:  Yi Lu; Yiting Qiu; Jianping Qi; Meiqing Feng; Dianwen Ju; Wei Wu
Journal:  Int J Pharm       Date:  2015-02-11       Impact factor: 5.875

Review 4.  Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS.

Authors:  Caroline Bylda; Roland Thiele; Uwe Kobold; Dietrich A Volmer
Journal:  Analyst       Date:  2014-05-21       Impact factor: 4.616

5.  Isolation and characterization of proteolipids from rat liver (LSP) and kidney (KSP).

Authors:  D Jüngst; J Blumenstingl; W H Caselmann
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 7.  New anticancer agents: recent developments in tumor therapy.

Authors:  Riyasat Ali; Zeenat Mirza; Ghulam M D Ashraf; Mohammad Amjad Kamal; Shakeel Ahmed Ansari; Ghazi Abdullah Damanhouri; Adel Mohammad Abuzenadah; Adeel Ga Chaudhary; Ishfaq Ahmed Sheikh
Journal:  Anticancer Res       Date:  2012-07       Impact factor: 2.480

8.  BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.

Authors:  Seong Il Seo; Lajos Gera; Haiyen E Zhau; Wei Ping Qian; Shareen Iqbal; Nicole A Johnson; Shumin Zhang; Majd Zayzafoon; John Stewart; Ruoxiang Wang; Leland W K Chung; Daqing Wu
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

10.  Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials.

Authors:  Miguel López-Lázaro
Journal:  Oncoscience       Date:  2015-02-20
View more
  1 in total

1.  Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.

Authors:  Xin Li; Lajos Gera; Shumin Zhang; Yanhua Chen; Lei Lou; Lauren Marie Wilson; Zhong-Ru Xie; Giuseppe Sautto; Degang Liu; Alira Danaher; Kenza Mamouni; Yang Yang; Yuhong Du; Haian Fu; Omer Kucuk; Adeboye O Osunkoya; Jia Zhou; Daqing Wu
Journal:  Theranostics       Date:  2021-05-08       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.